JADEITE MEDICINES

Company Overview

• Focusing on high unmet medical needs, Jadeite Medicines is a biopharmaceutical platform company focused on developing global innovative pharmaceutical products for Japan
  • Deep research and knowledge of high unmet clinical needs for Japan. We take a collaborative approach and partner with CROs and develop for the Japan market
  • An integrated industry-leading business development platform led by reputable Japanese pharmaceutical industry leaders and experienced global business development veterans
  • Accelerate open-innovation within the pharmaceutical industry in Japan
• Backed by CBC Group (formerly C-Bridge Capital) we will accelerate pipeline build up and development

Business model

• In license products from biotechs around the globe for Japan
• For the in licensed products, Jadeite Medicines will lead all clinical development for Japan
• Partner with pharmaceutical companies in Japan for commercialization at submission or after approval
• For some rare and orphan indications, Jadeite Medicines will develop and commercialize for the Japan market
• Structured financing for pharmaceutical companies doing business in Japan

Value proposition

• Licensing

  BD team with strong connectivity in the global biotech industry and extensive transaction track record

  

• Development

  Local management and development team with decades of experience in drug development and commercialization

  

• Financing

  Investment consortium led by CBC and other local investors, deep experience in capital markets to provide flexible financing solutions for pharmacos